Scarica l'app Stockscreener
22.05
7.35%
-1.75
Dopo l'orario di chiusura:
22.05
Lyell Immunopharma Inc Borsa (LYEL) Ultime notizie
Lyell Immunopharma (LYEL) to Release Earnings on Tuesday - MarketBeat
Lyell Immunopharma Advances GCC19CART Trial in Metastatic Colorectal Cancer: What Investors Should Know - TipRanks
LYEL.O Technical Analysis & Stock Price Forecast - Intellectia AI
LYEL Technical Analysis & ETF Price Forecast - Intellectia AI
Lyell Immunopharma Announces Participation in March Investor Conferences - GlobeNewswire
Cancer therapy developer Lyell to join three investor conferences in March - Stock Titan
What is the long term forecast for Lyell Immunopharma Inc. stockEarnings Recap Report & Risk Managed Investment Strategies - mfd.ru
How Lyell Immunopharma Inc. stock reacts to global recession fearsPortfolio Risk Report & Weekly Return Optimization Plans - mfd.ru
What’s the MACD signal for Lyell Immunopharma Inc.Portfolio Value Summary & Free Verified High Yield Trade Plans - mfd.ru
Is Lyell Immunopharma Inc. stock gaining market shareWeekly Trend Recap & Stock Market Timing Techniques - mfd.ru
Can Lyell Immunopharma Inc. stock beat market expectations this quarterJuly 2025 Movers & Reliable Intraday Trade Alerts - mfd.ru
Will Lyell Immunopharma Inc. stock deliver shareholder valueMarket Trend Review & Fast Gaining Stock Strategy Reports - mfd.ru
Aug Spikes: Will Lyell Immunopharma Inc benefit from rate cutsJuly 2025 Volume & Daily Risk Controlled Trade Plans - baoquankhu1.vn
Lyell Immunopharma (NASDAQ:LYEL) Shares Gap DownHere's Why - MarketBeat
Lyell Immunopharma, Inc. (NASDAQ:LYEL) Short Interest Up 28.0% in January - MarketBeat
Can Lyell Immunopharma Inc. maintain sales growthJuly 2025 Outlook & Fast Moving Stock Trade Plans - mfd.ru
Institution Moves: Can Lyell Immunopharma Inc maintain sales growth2025 Retail Activity & Short-Term Trading Opportunity Alerts - baoquankhu1.vn
LYEL Should I Buy - Intellectia AI
Lyell starts first-of-its-kind CAR-T trial; New coalition aims to boost European biotechs - BioPharma Dive
Lyell Immunopharma (NASDAQ:LYEL) COO Stephen Hill Sells 1,236 Shares - MarketBeat
Lyell Immunopharma (NASDAQ:LYEL) Insider Sells $39,084.69 in Stock - MarketBeat
Insider Selling: Lyell Immunopharma (NASDAQ:LYEL) CEO Sells 7,455 Shares of Stock - MarketBeat
Lyell Immunopharma (NASDAQ:LYEL) Trading Up 7.3%Should You Buy? - MarketBeat
Lyell Immunopharma Announces Initiation Of Patient Dosing In First-Of-Its-Kind Phase 3 Car T-Cell Clinical Trial - TradingView
Lyell Immunopharma, Inc. (Lyell) announced that dosing has begun for patients with aggressive large B-cell lymphoma in a groundbreaking Phase 3 clinical trial. - Bitget
Inside the first head-to-head CAR T cancer trial testing Lyell’s ronde-cel - Stock Titan
Sentiment Review: Is Lyell Immunopharma Inc. stock gaining market shareJuly 2025 Selloffs & Smart Allocation Stock Reports - mfd.ru
Insider Selling: Lyell Immunopharma (NASDAQ:LYEL) CEO Sells 438 Shares of Stock - MarketBeat
Is Lyell Immunopharma Inc. stock trending bullishBreakout Watch & Daily Profit Maximizing Tips - mfd.ru
Lyell (LYEL) CEO Lynn Seely granted 155,000 options and sells shares for taxes - Stock Titan
Lyell Immunopharma (LYEL) grants CSO 50,000 options, small share sale - Stock Titan
Pullback Watch: Is Lyell Immunopharma Inc stock trending bullishJuly 2025 Setups & Daily Profit Focused Screening - baoquankhu1.vn
How do insiders feel about American Express CompanyIPO Watch & Technical Analysis for Trade Confirmation - baoquankhu1.vn
Lyell Immunopharma, Inc. (NASDAQ:LYEL) Sees Significant Growth in Short Interest - MarketBeat
Lyell Immunopharma (NASDAQ:LYEL) Shares Gap UpShould You Buy? - MarketBeat
Lyell Immunopharma (NASDAQ:LYEL) Trading 13.4% HigherWhat's Next? - MarketBeat
Earnings Beat: How volatile is Lyell Immunopharma Inc stock2025 Technical Patterns & Smart Allocation Stock Tips - baoquankhu1.vn
Lyell Immunopharma, Inc. (NASDAQ:LYEL) Short Interest Update - Defense World
Entry Recap: Will Lyell Immunopharma Inc benefit from rate cutsExit Point & AI Forecast for Swing Trade Picks - baoquankhu1.vn
EPS Watch: What is the long term forecast for Lyell Immunopharma Inc stockPrice Action & Advanced Technical Signal Analysis - baoquankhu1.vn
How rising interest rates impact Lyell Immunopharma Inc. stock2025 Major Catalysts & AI Optimized Trading Strategy Guides - Улправда
Will Lyell Immunopharma Inc. stock benefit from automation2025 Price Targets & Fast Entry Momentum Trade Alerts - ulpravda.ru
Lyell Immunopharma (NASDAQ:LYEL) Shares Down 4.6%Here's Why - MarketBeat
Should I hold or sell Lyell Immunopharma Inc. stock in 2025Market Profile Overview & Low Cost Wealth Investment - bollywoodhelpline.com
Lyell Immunopharma (NASDAQ:LYEL) Shares Up 4.2%Still a Buy? - MarketBeat
Lyell Immunopharma (NASDAQ:LYEL) Trading Down 6.7% – Should You Sell? - Defense World
Lyell Immunopharma (NASDAQ:LYEL) Shares Down 6.7%Here's Why - MarketBeat
The Zacks Analyst Blog Mineralys, Lyell, Insmed and Nektar - sharewise.com
Critical Review: Lipocine (NASDAQ:LPCN) & Lyell Immunopharma (NASDAQ:LYEL) - Defense World
4 Drug, Biotech Stocks Rising More Than 50% in 2025 With Room to Grow - Yahoo Finance
Lyell Immunopharma: LYL314 Drives Momentum Amid Strong ASH Data (NASDAQ:LYEL) - Seeking Alpha
Precision's Payoff: Targeted Therapies Drive $131B Solid Tumor Market Surge - GlobeNewswire
3.69%
0.68%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):